Richard M. Ashworth - Apr 12, 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
President and CEO, Director
Signature
/s/ Jennifer Guckert Griffin, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Apr 12, 2023
Transactions value $
$0
Form type
4
Date filed
4/14/2023, 05:29 PM
Previous filing
Apr 14, 2023
Next filing
Jun 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +31.3K $0.00 31.3K Apr 12, 2023 Direct F1
transaction AMED Common Stock Award $0 +15.7K +50% $0.00 47K Apr 12, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMED Stock Option (Right to Buy) Award $0 +33.7K $0.00 33.7K Apr 12, 2023 Common Stock 33.7K $79.82 Direct F3
transaction AMED Restricted Stock Unit (Performance-Based Vesting) Award $0 +31.3K $0.00 31.3K Apr 12, 2023 Common Stock 31.3K Direct F4
transaction AMED Restricted Stock Unit (Performance-Based Vesting) Award $0 +62.6K $0.00 62.6K Apr 12, 2023 Common Stock 62.6K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 31,321 time-based restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest on April 12, 2024, provided that the Reporting Person remains continuously employed by the Issuer on such date.
F2 The Issuer awarded the Reporting Person 15,661 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F3 The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F4 The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved.
F5 The performance-based RSUs will vest based on the Company's achievement of a pre-established performance measure over a three-year performance period, and the amount earned based on the level of performance achieved will cliff vest on April 12, 2028, assuming the Reporting Person remains continuously employed by the Issuer on such date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 300% of the amount reported depending on the level of performance achieved.